Mission Pharmacal enters into agreement with MainPointe Pharmaceuticals to purchase and license Mission’s consumer products

Mission will continue manufacturing most products involved in the agreement; it is anticipated that product sales will increase due to MainPointe’s heightened consumer focus.

SAN ANTONIO (February 21, 2018) – Mission Pharmacal Company (“Mission”) announced today that it has recently divested several consumer products to MainPointe Pharmaceuticals, LLC (“MainPointe”). In addition, the marketing rights of additional consumer products have been licensed by Mission to MainPointe. As part of these transactions, the companies have also entered into a renewable Contract Manufacturing Agreement to continue manufacturing all of the included products that are currently made in Mission’s manufacturing facility. These agreements do not involve the marketing or manufacturing of any of Mission’s branded prescription medications.

Mission Pharmacal Company consumer products included in recent divestment and marketing rights transfer agreements with MainPointe Pharmaceuticals, LLC.

Mission Pharmacal Company consumer products
included in recent divestment and marketing
rights transfer agreements with
MainPointe Pharmaceuticals, LLC.

“These are exciting agreements that will provide consumers greater access to the products involved due to MainPointe’s existing relationships within more diverse distribution channels,” says Mission President Neill Walsdorf, Jr. “Mission remains passionate about the products involved, and more importantly, we are steadfast in our support of the end users who rely on these products every day.”
As part of the agreements, the following product lines have been divested:

  • Thera-Gesic® (dual-action, pain relieving creme)
  • Thera-Gesic® Plus
  • Dr. Smith’s® Diaper Rash Ointment (pediatrician-developed, diaper rash treatment)
  • Dr. Smith’s® Diaper Rash Spray
  • Dr. Smith’s® Adult Barrier Spray (treatment and preventative for incontinence-associated dermatitis)
  • Dr. Smith’s® Adult Ointment

In addition, marketing rights have been licensed by Mission to MainPointe for the following product lines:

  • Calcet® (calcium supplement option for a broad range of patients)
  • Fosfree® (calcium, vitamins, and iron supplement)
  • Heat Guard® (sodium and potassium chloride supplement)
  • Maxilube® (personal lubricant)
  • Lycelle® Head Lice Removal Kit (pesticide free, head lice eliminator)

Beyond its core pharmaceutical business, Mission is the parent company of the Mission Family of Companies, a group of wholly-owned subsidiaries that function independently, with collective product and service offerings that can be scaled to provide customizable solutions to meet the needs of its business partners. Specific to the MainPointe agreements, BexR Logistix, LLC and its subsidiary EPIC Fulfillment, Inc. have the infrastructure in place to provide warehousing and fulfillment. Alamo Pharma Services, Inc. is well positioned to provide sales support and sales force training.

“We look at these agreements as the beginning of an exciting strategic partnership between Mission and MainPointe,” notes Walsdorf. “Our industry is continually evolving and we hold strong to the belief that partnering for success is more essential today than ever before.”
 

About Mission Pharmacal Company
Mission Pharmacal Company is a privately held pharmaceutical company based in San Antonio, Texas. For more than seven decades, the company has been improving the lives of people through every stage of life by identifying unmet healthcare needs, and then manufacturing and delivering innovative, high-quality prescription, over-the-counter, and dietary supplement products to meet these needs using only the purest ingredients and FDA-approved methods of manufacturing. Mission is recognized as a pioneer and leader in the therapeutic areas of women’s health and urology and also offers leading products through its pediatric, dermatology, primary care, and long-term care service lines. With the shared objective of improving the health of all moms and babies, Mission is proud to support the March of Dimes Foundation®, the leading nonprofit organization for pregnancy and baby health.

Using an innovative business model, Mission created the Mission Family of Companies, a collection of wholly-owned subsidiaries including BioComp Pharma, Inc., a generic drug marketer; Alamo Pharma Services, Inc., a specialized contract sales organization; ProSolus, Inc., a transdermal drug developer and manufacturer; Espada Dermatology, Inc., a prescription and esthetic dermatology company; as well as BexR Logistix, LLC and its subsidiary company, EPIC Fulfillment, Inc., the logistics and fulfillment arms of the organization. Each company functions independently while their product and service offerings can be linked together to offer customizable solutions to a wide array of forward-thinking pharmaceutical and biotech companies. To learn more, please visit missionfamilyofcompanies.com.

# # #


Mission Contact:                            
Drew Deeter                                
DeeterUSA                                
Integrated Marketing                            
and Communications                            
215.348.3890                                
[email protected]